HUP0201763A3 - Microreservoir system on the basis of polysiloxanes and ambiphilic solvents - Google Patents

Microreservoir system on the basis of polysiloxanes and ambiphilic solvents

Info

Publication number
HUP0201763A3
HUP0201763A3 HU0201763A HUP0201763A HUP0201763A3 HU P0201763 A3 HUP0201763 A3 HU P0201763A3 HU 0201763 A HU0201763 A HU 0201763A HU P0201763 A HUP0201763 A HU P0201763A HU P0201763 A3 HUP0201763 A3 HU P0201763A3
Authority
HU
Hungary
Prior art keywords
polysiloxanes
basis
microreservoir system
ambiphilic solvents
ambiphilic
Prior art date
Application number
HU0201763A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19958554A external-priority patent/DE19958554C2/de
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of HUP0201763A2 publication Critical patent/HUP0201763A2/hu
Publication of HUP0201763A3 publication Critical patent/HUP0201763A3/hu
Publication of HU229085B1 publication Critical patent/HU229085B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
HU0201763A 1999-07-02 2000-06-20 Microreservoir system on the basis of polysiloxanes and ambiphilic solvents HU229085B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19930340 1999-07-02
DE19958554A DE19958554C2 (de) 1999-07-02 1999-12-04 Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
PCT/EP2000/005658 WO2001001967A1 (de) 1999-07-02 2000-06-20 Mikroreservoirsystem auf basis von polysiloxanen und ambiphilen lösemitteln

Publications (3)

Publication Number Publication Date
HUP0201763A2 HUP0201763A2 (hu) 2002-12-28
HUP0201763A3 true HUP0201763A3 (en) 2004-05-28
HU229085B1 HU229085B1 (en) 2013-07-29

Family

ID=26054014

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201763A HU229085B1 (en) 1999-07-02 2000-06-20 Microreservoir system on the basis of polysiloxanes and ambiphilic solvents

Country Status (22)

Country Link
US (2) US10532033B2 (hu)
EP (1) EP1191927B1 (hu)
JP (1) JP4428899B2 (hu)
CN (1) CN1195505C (hu)
AT (1) ATE234081T1 (hu)
AU (1) AU774740B2 (hu)
BR (1) BR0012152A (hu)
CA (1) CA2374930C (hu)
CZ (1) CZ301726B6 (hu)
DK (1) DK1191927T3 (hu)
ES (1) ES2194736T3 (hu)
HK (1) HK1047234B (hu)
HU (1) HU229085B1 (hu)
IL (1) IL147247A0 (hu)
MX (1) MXPA02000118A (hu)
NZ (1) NZ515953A (hu)
PL (1) PL197492B1 (hu)
PT (1) PT1191927E (hu)
RU (1) RU2263502C2 (hu)
TR (1) TR200103845T2 (hu)
TW (2) TWI255723B (hu)
WO (1) WO2001001967A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU229085B1 (en) 1999-07-02 2013-07-29 Lohmann Therapie Syst Lts Microreservoir system on the basis of polysiloxanes and ambiphilic solvents
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
PL219512B1 (pl) 2003-04-14 2015-05-29 Lohmann Therapie Syst Lts Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego
DE102004044578A1 (de) 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
KR100764679B1 (ko) * 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
DE102007041557B4 (de) * 2007-08-29 2011-03-31 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend längliche Hohlkörper
CN104114161A (zh) 2011-12-12 2014-10-22 Lts勒曼治疗系统股份公司 包含丁丙诺啡的经皮递送系统
DE102011090178A1 (de) 2011-12-30 2013-07-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
WO2014195352A1 (en) * 2013-06-04 2014-12-11 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system
BR112015032929B1 (pt) 2013-07-03 2022-08-23 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico com componente eletrônico e métodos de produção de um sistema terapêutico transdérmico
EP2946776A1 (de) 2014-05-20 2015-11-25 LTS LOHMANN Therapie-Systeme AG Transdermales therapeutisches System zur Abgabe von Amitriptylin
CN106456567A (zh) 2014-05-20 2017-02-22 Lts勒曼治疗系统股份公司 在经皮递送系统中调节活性剂释放的方法
US11752110B2 (en) 2014-05-20 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an interface mediator
CN106456566B (zh) 2014-05-20 2020-06-16 Lts勒曼治疗系统股份公司 含罗替戈汀的经皮递送系统
BR112020003314A2 (pt) * 2017-09-04 2020-08-25 Lts Lohmann Therapie-Systeme Ag sistema de liberação transdérmico incluindo um emulsificante

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
GB1361289A (en) 1971-06-14 1974-07-24 Alza Corp Bandage for administering drugs
US3946106A (en) 1974-10-24 1976-03-23 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4053580A (en) 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4036228A (en) 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
DE3333240A1 (de) 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
EP0196769B1 (en) 1985-02-25 1992-07-08 Rutgers, The State University of New Jersey A novel transdermal pharmaceutical absorption dosage unit
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US5145682A (en) 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
GB8704755D0 (en) 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
CH674618A5 (hu) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
EP0370220B1 (de) 1988-10-27 1996-01-10 Schering Aktiengesellschaft Mittel zur transdermalen Applikation enthaltend Gestoden
DE3910578A1 (de) 1989-03-29 1990-10-04 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4332093C2 (de) 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
US5688523A (en) * 1995-03-31 1997-11-18 Minnesota Mining And Manufacturing Company Method of making a pressure sensitive skin adhesive sheet material
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
FR2740038B1 (fr) 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US6381852B1 (en) 1998-08-17 2002-05-07 Dart Industries, Inc. Pastry cutter set with combined storage case and support
HUP9802963A1 (hu) 1998-12-18 2000-12-28 József Bereznai Szagelszívás közvetlen a WC-csészéből és az ezt biztosító szerkezet
HU229085B1 (en) 1999-07-02 2013-07-29 Lohmann Therapie Syst Lts Microreservoir system on the basis of polysiloxanes and ambiphilic solvents

Also Published As

Publication number Publication date
AU5222000A (en) 2001-01-22
US20040202710A1 (en) 2004-10-14
TW200425916A (en) 2004-12-01
PL197492B1 (pl) 2008-04-30
BR0012152A (pt) 2002-03-12
CN1195505C (zh) 2005-04-06
CZ20014514A3 (cs) 2002-03-13
US10532033B2 (en) 2020-01-14
CN1356895A (zh) 2002-07-03
CA2374930A1 (en) 2001-01-11
HU229085B1 (en) 2013-07-29
RU2263502C2 (ru) 2005-11-10
JP2003503445A (ja) 2003-01-28
IL147247A0 (en) 2002-08-14
ATE234081T1 (de) 2003-03-15
NZ515953A (en) 2003-06-30
HUP0201763A2 (hu) 2002-12-28
MXPA02000118A (es) 2003-02-27
JP4428899B2 (ja) 2010-03-10
HK1047234B (zh) 2005-07-29
PT1191927E (pt) 2003-07-31
CA2374930C (en) 2008-08-05
DK1191927T3 (da) 2003-05-26
HK1047234A1 (en) 2003-02-14
EP1191927B1 (de) 2003-03-12
CZ301726B6 (cs) 2010-06-02
ES2194736T3 (es) 2003-12-01
US10709669B2 (en) 2020-07-14
TWI256311B (en) 2006-06-11
PL352361A1 (en) 2003-08-11
US20200060985A1 (en) 2020-02-27
TWI255723B (en) 2006-06-01
AU774740B2 (en) 2004-07-08
EP1191927A1 (de) 2002-04-03
WO2001001967A1 (de) 2001-01-11
TR200103845T2 (tr) 2002-05-21

Similar Documents

Publication Publication Date Title
ZA200110455B (en) Microreservoir system on the basis of polysiloxanes and ambiphilic solvents.
HUP0201763A3 (en) Microreservoir system on the basis of polysiloxanes and ambiphilic solvents
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
IL148545A0 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
GB0007353D0 (en) Oxime derivatives and the use therof as latent acids
MXPA02001375A (es) Inhabilitacion de equipo con base de tiempos.
AU4145200A (en) Cyclic compounds and uses thereof
HUP0202780A3 (en) Selective herbicides on the basis of n-aryl-triazoline(thi)ones
EP1153602A4 (en) SKIN PREPARATIONS FOR EXTERNAL USE
HUP0202150A2 (en) Use of nitric oxide donors for inducing neurogenesis
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
ZA200204047B (en) The genome of the HV-1 inter-subtype (C/B') and use thereof.
IL129179A0 (en) Cyclic glycerophosphates and analogs thereof
GB2341656B (en) Assembly system and components therefor
IL128111A0 (en) An expression silencing system and different uses thereof
PL354184A1 (en) The prv-1 gene and use thereof
GB9929074D0 (en) Releasable retaining devices
PL350128A1 (en) Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
TW390421U (en) The structure of a simple exhaust system
GB9927353D0 (en) Virus preparation and use
IL146605A0 (en) Immunogenic peptides derived from mage and the use thereof
IL145299A0 (en) Cyclic glycerophosphates and analogs thereof
NZ513706A (en) External operation device and entertainment system
ZA964250B (en) 2-amino-benzoxazinones for the treatment of viral infections.